Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects.
Kaposi's sarcoma-associated herpesvirus (KSHI) is one of the few viruses proven to be associated with tumorigenesis in humans. Its causal association with all clinical and epidemiological variants of Kaposi's sarcoma (KS) is well established. KSHV is also involved in the pathogenesis of primary effusion lymphoma (PEL) and a subset of multicentric Castleman's disease (MCD). Possible associations of KSHV with other clinical settings have been extensively examined. The findings from several of these studies are contradictory and are yet to be resolved. Concentrated effort over the last decade, since the initial discovery of KSHV, led to the development of several experimental systems that resulted in a better comprehension of the biological characteristics of KSHV and set the stage for the understanding of mechainisms by which diseases are induced by the virus. The development of molecular, histological, and serological tools for KSHV diagnosis allowed researchers to track the transmission and to study the epidemiology of KSHV. These assays have been applied, in particular in ambiguous cases, in order to confirm clinically and pathologically based diagnoses. Here, we review the advances in the clinical, experimental, diagnostic, and epidemiological research of KSHV.
Cohen
Adina
A
Faculty of Life Sciences, Bar-Ilan Universiy, Ramat-Gan, Israel.
Wolf
Dana G
DG
Guttman-Yassky
Emma
E
Sarid
Ronit
R
D019288:Herpesvirus 8, Human / Q000472:pathogenicity*; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D012514:Sarcoma, Kaposi / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology / Q000821:virology*; D014764:Viral Proteins / Q000378:metabolism
D014764:Viral Proteins